Brain Lesion in the Setting of Chronic Rituximab Treatment

JAMA Oncol. 2020 Jul 1;6(7):1093-1094. doi: 10.1001/jamaoncol.2020.0160.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Brain / diagnostic imaging
  • Clostridium Infections / complications
  • Fatal Outcome
  • Female
  • Humans
  • JC Virus / isolation & purification
  • Leukoencephalopathy, Progressive Multifocal / cerebrospinal fluid
  • Leukoencephalopathy, Progressive Multifocal / diagnostic imaging
  • Leukoencephalopathy, Progressive Multifocal / drug therapy
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Lymphoma, Follicular / drug therapy
  • Magnetic Resonance Imaging
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use
  • Shock, Septic / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Rituximab
  • pembrolizumab